Bausch Health Companies Inc. - BHC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | — | A | A | 11,574.0 | 5.4 | 62,499.6 | 371,694.0 | View | |
| Apr 02, 2026 | — | A | A | 5,946.0 | 5.4 | 32,108.4 | 44,354.0 | View | |
| Apr 02, 2026 | — | A | A | 1,273.0 | 5.4 | 6,874.2 | 267,714.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | S | D | 4,420.0 | 5.77 | 25,503.4 | 616,761.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | J | D | 137,922.0 | 5.95 | 820,635.9 | 621,181.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | F | D | 16,973.0 | 5.95 | 100,989.35 | 759,103.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | S | D | 6,856.0 | 5.78 | 39,627.68 | 776,076.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | F | D | 26,326.0 | 5.93 | 156,113.18 | 782,932.0 | View | |
| Mar 03, 2026 | EVP, CFO | F | D | 49,060.0 | 5.93 | 290,925.8 | 706,478.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | J | D | 1,137,862.0 | 5.95 | 6,770,278.9 | 2,315,374.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | F | D | 83,705.0 | 5.95 | 498,044.75 | 3,453,236.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | F | D | 83,093.0 | 5.93 | 492,741.49 | 3,536,941.0 | View | |
| Feb 27, 2026 | EVP, CFO | F | D | 35,977.0 | 6.04 | 217,301.08 | 755,538.0 | View | |
| Feb 27, 2026 | EVP, CFO | A | A | 276,055.0 | 0.0 | 0.0 | 791,515.0 | View | |
| Feb 27, 2026 | EVP, General Counsel | S | D | 8,388.0 | 5.95 | 49,908.6 | 809,258.0 | View | |
| Feb 27, 2026 | EVP, General Counsel | F | D | 32,211.0 | 6.04 | 194,554.44 | 817,646.0 | View | |
| Feb 27, 2026 | EVP, General Counsel | A | A | 212,350.0 | 0.0 | 0.0 | 849,857.0 | View | |
| Feb 27, 2026 | EVP, US Pharma | F | D | 17,578.0 | 6.04 | 106,171.12 | 400,335.0 | View | |
| Feb 27, 2026 | EVP, US Pharma | A | A | 157,139.0 | 0.0 | 0.0 | 417,913.0 | View | |
| Feb 27, 2026 | SVP, Controller & CAO | A | A | 45,868.0 | 0.0 | 0.0 | 73,239.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | F | D | 116,502.0 | 6.04 | 703,672.08 | 3,620,034.0 | View | |
| Feb 27, 2026 | Chief Executive Officer | A | A | 815,425.0 | 0.0 | 0.0 | 3,736,536.0 | View | |
| Feb 11, 2026 | EVP, General Counsel | A | A | 137,922.0 | 0.0 | 0.0 | 637,507.0 | View | |
| Feb 11, 2026 | Chief Executive Officer | A | A | 1,137,862.0 | 0.0 | 0.0 | 2,921,111.0 | View | |
| Jan 02, 2026 | — | A | A | 4,586.0 | 0.0 | 0.0 | 38,408.0 | View | |
| Jan 02, 2026 | — | A | A | 8,992.0 | 0.0 | 0.0 | 360,120.0 | View | |
| Jan 02, 2026 | — | A | A | 989.0 | 0.0 | 0.0 | 266,441.0 | View | |
| Nov 28, 2025 | — | P | A | 2,500,000.0 | 6.25 | 15,625,000.0 | 73,255,869.0 | View |